Collagen peptide protein is a soluble protein supplement derived from bovine or marine protein. These proteins help to maintain bone, skin, and joint health. Moreover, enteral collagen peptide proteins provide hydrolyzed collagen directly in the gastrointestinal tract in patients who cannot swallow food or get enough nourishment by eating or drinking. This process of administrating nutrition involves the usage of enteral feeding devices such as pumps and tubes. These medical devices deliver the medications and nutrients directly into the stomach, duodenum, or jejunum either via the nose, mouth, or direct percutaneous route.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
The key players profiled in this report include Abbott laboratories, Danone S.A (Nutricia). Dermarites Industries LLC, Medtronic, Inc, Medline Industries, Inc, Global Health Products, Inc., OP2 labs, LLC, fresenius Kabi AG, Gelita AG, and Weishardt Holding SA.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/14044
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
- On the basis of form, the liquid segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
- By age group, the adults (above 18) segment dominated the market in 2020, in terms of share, and is expected to lead in the near future.
- Depending on end user, the homecare segment held largest market share in 2020, and is expected to remain dominant throughout the forecast period.
- Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.2% during the forecast period.
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. Lockdown, government regulations, and continuous increase in infection rate across the country created a widespread financial impact on neurology hospitals and clinics. Large number of hospitals and clinics have witnessed a drop in number of patient visits amid COVID-19 ultimately reducing client contact.
The overall impact of COVID-19 remains negative for enteral collagen peptide protein, owing to decline in meat consumption, especially marine and bovine products, across the globe. In addition, COVID-19 pandemic has affected the enteral collagen peptide protein products production and import & export of finished goods, owing to lockdown in various COVID-19-affected countries and rise in number of healthcare workers falling ill during the pandemic, leading to short supply. Temporary disruptions of inputs or production might stress some companies, particularly those with inadequate liquidity. Moreover, delayed shipments & production schedules create financial problems for companies with heavy debts. Thus, the enteral collagen peptide protein market has been negatively impacted due to the current global health crisis.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/14044
On the basis of age group, the market is bifurcated into adults and pediatric. The adult (above18) segment accounted for maximum revenue in 2020, and is anticipated to gain prominence during the forecast period, owing to higher number of patients suffering from osteoarthritis, osteoporosis, and rheumatoid arthritis. Furthermore, increase in geriatric population that requires enteral collagen peptide protein and has difficulty in swallowing is expected to contribute to the market growth
By end user, the market is categorized into hospital & clinics, homecare and nursing home. The homecare segment is anticipated to depict significant growth during the forecast period. This is attributed to increase in number of patients adopting enteral collagen peptide protein administration at home and increase in demand for home care enteral collagen peptide protein treatment. Moreover, increase in geriatric population, urbanization & industrialization, rising per capita income and high investments in research and development activities to produce collagen peptide protein-based products drives the growth of the market.
๐๐ฒ๐ ๐๐ฒ๐๐ฎ๐ถ๐น๐ฒ๐ฑ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/enteral-collagen-peptide-protein-market-A13675
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com